Search Results - "KOCH, Alvaro"

Refine Results
  1. 1
  2. 2

    Predictors of Relapse to Alcohol and Illicit Drugs After Liver Transplantation for Alcoholic Liver Disease by GEDALY, Roberto, MCHUGH, Patrick P, JOHNSTON, Thomas D, JEON, Hoonbae, KOCH, Alvaro, CLIFFORD, Timothy M, RANJAN, Dinesh

    Published in Transplantation (27-10-2008)
    “…Alcoholic liver disease (ALD) is a common indication for transplantation worldwide. This study identifies factors predicting posttransplant recidivism…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Recurrent autoimmune hepatitis after orthotopic liver transplantation by González-Koch, Alvaro, Czaja, Albert J., Carpenter, Herschel A., Roberts, Stuart K., Charlton, Michael R., Porayko, Michael K., Rosen, Charles B., Wiesner, Russell H.

    Published in Liver transplantation (01-04-2001)
    “…To determine the frequency, risk factors, and consequences of recurrent autoimmune hepatitis after liver transplantation, 41 patients with type 1 disease were…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Medical Management of Common Bile Duct Stones by González‐Koch, Alvaro, Nervi, Flavio

    Published in World journal of surgery (01-11-1998)
    “…Common bile duct stones are a common cause of morbidity and mortality in adults. An increasing number of surgical and medical therapies are available to manage…”
    Get full text
    Journal Article
  8. 8

    Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma by McHugh, Patrick P., Gilbert, Jeffrey, Vera, Santiago, Koch, Alvaro, Ranjan, Dinesh, Gedaly, Roberto

    Published in HPB (Oxford, England) (01-02-2010)
    “…To determine factors associated with outcomes and microvascular invasion (MVI) in patients undergoing liver transplantation (LT) for hepatocellular carcinoma…”
    Get full text
    Journal Article
  9. 9

    PI-103 and Sorafenib Inhibit Hepatocellular Carcinoma Cell Proliferation by Blocking Ras/Raf/MAPK and PI3K/AKT/mTOR Pathways by GEDALY, Roberto, ANGULO, Paul, HUNDLEY, Jonathan, DAILY, Michael F, CHANGGUO CHEN, KOCH, Alvaro, EVERS, B. Mark

    Published in Anticancer research (01-12-2010)
    “…Aberrant Ras/Raf/MAPK and PI3K/AKT/mTOR signaling pathways are found in hepatocellular carcinoma (HCC). This study reports how sorafenib (a multi-kinase…”
    Get full text
    Journal Article
  10. 10

    Bone Disease in Patients With Primary Sclerosing Cholangitis by Angulo, Paul, Grandison, Garfield A, Fong, Derek G, Keach, Jill C, Lindor, Keith D, Bjornsson, Einar, Koch, Alvaro

    Published in Gastroenterology (New York, N.Y. 1943) (01-01-2011)
    “…Background & Aims Osteopenic bone disease occurs frequently among patients with chronic liver disease but has not been well studied in those with primary…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Diffuse malignant infiltration of the liver manifesting as a case of acute liver failure by Koch, Alvaro, Gilbert, Jeffrey, Rutledge, Heather

    “…This article considers the case of a 54-year-old male with a history of coronary artery disease, diabetes mellitus and tobacco abuse who presented with right…”
    Get full text
    Journal Article
  13. 13

    Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database by Gedaly, Roberto, Daily, Michael F, Davenport, Daniel, McHugh, Patrick P, Koch, Alvaro, Angulo, Paul, Hundley, Jonathan C

    Published in Archives of surgery (Chicago. 1960) (01-08-2011)
    “…To determine outcomes in patients undergoing liver transplantation (LT) for metastatic neuroendocrine tumors (NETs). Retrospective analysis. University of…”
    Get more information
    Journal Article
  14. 14

    Viral Hepatitis and Injection Drug Use in Appalachian Kentucky: A Survey of Rural Health Department Clients by Christian, W. Jay, Hopenhayn, Claudia, Christian, Amy, McIntosh, Deana, Koch, Alvaro

    Published in Public health reports (1974) (01-01-2010)
    “…Objectives. We identified correlates of exposure to hepatitis and viruses among health department clients in Appalachian Kentucky, a rural region noted for…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone by GONZALEZ-KOCH, A, BRAHM, J, ANTEZANA, C, SMOK, G, CUMSILLE, M. A

    Published in Journal of hepatology (01-07-1997)
    “…Many therapies have been tried in primary biliary cirrhosis. It has been suggested that a combination of ursodeoxycholic acid and methotrexate may offer…”
    Get full text
    Journal Article